Medlab Clinical $6.600
(0.00%)
|
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 4:00am | ||||
MEDLAB CLINICAL LIMITED
Pharmaceuticals, Biotechnology & Life Sciences
|
Market Cap (14-Nov) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
NanoCelle Nasal RNA (Nucleid Acid) Program Update
MDC released this announcement to the ASX on 10 November 2022, 10:59. The announcement is marked as price sensitive, and is 2 page(s) in length and 158.76kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| NanoCelle Nasal RNA (Nucleid Acid) Program Update | 10 November 2022, 10:59 |
| Medlab Presents NanoCelle at Jefferies Conference London | 9 November 2022, 13:03 |
| Notification of cessation of securities - MDC | 1 November 2022, 7:42 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 October 2022, 9:02 |
If you were already registered, log in here.
If you were already registered, log in here.